Listed

Apyx Medical Corp

APYXNasdaqCIK 719135HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$13.9m, Q2 FY2026
Operating income−$1.8m, Q2 FY2026
Net income−$3.2m, Q2 FY2026
Apyx Medical Corp, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m12.0Revenue, Q3 FY2023, three months to 2023-09-30$12.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-08, accession 0001437749-24-034193.Report this figure14.7Revenue, Q4 FY2023, three months to 2023-12-31$14.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-13, accession 0001437749-25-007521. Derived: 12-month figure less the 9-month figure.Report this figure10.2Revenue, Q1 FY2024, three months to 2024-03-31$10.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0001437749-25-015356.Report this figure12.1Revenue, Q2 FY2024, three months to 2024-06-30$12.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001437749-25-025422.Report this figure11.5Revenue, Q3 FY2024, three months to 2024-09-30$11.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure14.2Revenue, Q4 FY2024, three months to 2024-12-31$14.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure9.4Revenue, Q1 FY2025, three months to 2025-03-31$9.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure11.4Revenue, Q2 FY2025, three months to 2025-06-30$11.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure12.9Revenue, Q3 FY2025, three months to 2025-09-30$12.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure19.2Revenue, Q4 FY2025, three months to 2025-12-31$19.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure12.5Revenue, Q1 FY2026, three months to 2026-03-31$12.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure13.9Revenue, Q2 FY2026, three months to 2026-06-30$13.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure
Cost of revenue$m4.0Cost of revenue, Q3 FY2023, three months to 2023-09-30$4.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-08, accession 0001437749-24-034193.Report this figure5.7Cost of revenue, Q4 FY2023, three months to 2023-12-31$5.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-03-13, accession 0001437749-25-007521. Derived: 12-month figure less the 9-month figure.Report this figure4.3Cost of revenue, Q1 FY2024, three months to 2024-03-31$4.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-08, accession 0001437749-25-015356.Report this figure4.7Cost of revenue, Q2 FY2024, three months to 2024-06-30$4.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-07, accession 0001437749-25-025422.Report this figure4.5Cost of revenue, Q3 FY2024, three months to 2024-09-30$4.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure5.3Cost of revenue, Q4 FY2024, three months to 2024-12-31$5.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure3.8Cost of revenue, Q1 FY2025, three months to 2025-03-31$3.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure4.3Cost of revenue, Q2 FY2025, three months to 2025-06-30$4.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure4.6Cost of revenue, Q3 FY2025, three months to 2025-09-30$4.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure7.2Cost of revenue, Q4 FY2025, three months to 2025-12-31$7.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure4.6Cost of revenue, Q1 FY2026, three months to 2026-03-31$4.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure5.0Cost of revenue, Q2 FY2026, three months to 2026-06-30$5.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure
Gross profit$m8.0Gross profit, Q3 FY2023, three months to 2023-09-30$8.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-08, accession 0001437749-24-034193.Report this figure8.9Gross profit, Q4 FY2023, three months to 2023-12-31$8.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-13, accession 0001437749-25-007521. Derived: 12-month figure less the 9-month figure.Report this figure5.9Gross profit, Q1 FY2024, three months to 2024-03-31$5.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-08, accession 0001437749-25-015356.Report this figure7.5Gross profit, Q2 FY2024, three months to 2024-06-30$7.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-07, accession 0001437749-25-025422.Report this figure7.0Gross profit, Q3 FY2024, three months to 2024-09-30$7.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure9.0Gross profit, Q4 FY2024, three months to 2024-12-31$9.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure5.7Gross profit, Q1 FY2025, three months to 2025-03-31$5.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure7.1Gross profit, Q2 FY2025, three months to 2025-06-30$7.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure8.3Gross profit, Q3 FY2025, three months to 2025-09-30$8.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure12.0Gross profit, Q4 FY2025, three months to 2025-12-31$12.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure7.9Gross profit, Q1 FY2026, three months to 2026-03-31$7.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure8.9Gross profit, Q2 FY2026, three months to 2026-06-30$8.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure
Research and development$m1.4Research and development, Q3 FY2023, three months to 2023-09-30$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-08, accession 0001437749-24-034193.Report this figure1.4Research and development, Q4 FY2023, three months to 2023-12-31$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-13, accession 0001437749-25-007521. Derived: 12-month figure less the 9-month figure.Report this figure1.4Research and development, Q1 FY2024, three months to 2024-03-31$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0001437749-25-015356.Report this figure1.4Research and development, Q2 FY2024, three months to 2024-06-30$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001437749-25-025422.Report this figure1.1Research and development, Q3 FY2024, three months to 2024-09-30$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure1.1Research and development, Q4 FY2024, three months to 2024-12-31$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure0.8Research and development, Q1 FY2025, three months to 2025-03-31$804.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure0.8Research and development, Q2 FY2025, three months to 2025-06-30$824.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure0.8Research and development, Q3 FY2025, three months to 2025-09-30$801.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure0.9Research and development, Q4 FY2025, three months to 2025-12-31$944.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure0.8Research and development, Q1 FY2026, three months to 2026-03-31$765.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure0.8Research and development, Q2 FY2026, three months to 2026-06-30$793.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure
Selling, general and administrative$m4.8Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$4.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-08, accession 0001437749-24-034193.Report this figure6.7Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$6.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-13, accession 0001437749-25-007521. Derived: 12-month figure less the 9-month figure.Report this figure4.9Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$4.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-08, accession 0001437749-25-015356.Report this figure4.8Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$4.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0001437749-25-025422.Report this figure4.3Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$4.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure4.8Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$4.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure3.5Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$3.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure4.3Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$4.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure3.7Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$3.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure4.6Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$4.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure3.6Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$3.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure5.3Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$5.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure
Operating income$m(4.6)Operating income, Q3 FY2023, three months to 2023-09-30−$4.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-08, accession 0001437749-24-034193.Report this figure(5.8)Operating income, Q4 FY2023, three months to 2023-12-31−$5.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-13, accession 0001437749-25-007521. Derived: 12-month figure less the 9-month figure.Report this figure(6.6)Operating income, Q1 FY2024, three months to 2024-03-31−$6.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0001437749-25-015356.Report this figure(5.5)Operating income, Q2 FY2024, three months to 2024-06-30−$5.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001437749-25-025422.Report this figure(3.6)Operating income, Q3 FY2024, three months to 2024-09-30−$3.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure(3.0)Operating income, Q4 FY2024, three months to 2024-12-31−$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure(3.1)Operating income, Q1 FY2025, three months to 2025-03-31−$3.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure(2.6)Operating income, Q2 FY2025, three months to 2025-06-30−$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure(0.8)Operating income, Q3 FY2025, three months to 2025-09-30−$832.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure0.0Operating income, Q4 FY2025, three months to 2025-12-31$11.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure(0.9)Operating income, Q1 FY2026, three months to 2026-03-31−$911.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure(1.8)Operating income, Q2 FY2026, three months to 2026-06-30−$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure
Interest expense$m0.6Interest expense, Q3 FY2023, three months to 2023-09-30$585.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-09, accession 0000719135-23-000056.Report this figure1.1Interest expense, Q4 FY2023, three months to 2023-12-31$1.1m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-21, accession 0000719135-24-000016. Derived: 12-month figure less the 9-month figure.Report this figure1.4Interest expense, Q1 FY2024, three months to 2024-03-31$1.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-09, accession 0000719135-24-000026.Report this figure1.4Interest expense, Q2 FY2024, three months to 2024-06-30$1.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-08, accession 0000719135-24-000038.Report this figure1.4Interest expense, Q3 FY2024, three months to 2024-09-30$1.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure1.7Interest expense, Q4 FY2024, three months to 2024-12-31$1.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure1.4Interest expense, Q1 FY2025, three months to 2025-03-31$1.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure1.4Interest expense, Q2 FY2025, three months to 2025-06-30$1.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure1.4Interest expense, Q3 FY2025, three months to 2025-09-30$1.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure1.4Interest expense, Q4 FY2025, three months to 2025-12-31$1.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure1.4Interest expense, Q1 FY2026, three months to 2026-03-31$1.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure1.4Interest expense, Q2 FY2026, three months to 2026-06-30$1.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure
Income tax$m(0.3)Income tax, Q3 FY2023, three months to 2023-09-30−$318.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-08, accession 0001437749-24-034193.Report this figure0.1Income tax, Q4 FY2023, three months to 2023-12-31$87.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-13, accession 0001437749-25-007521. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2024, three months to 2024-03-31$53.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0001437749-25-015356.Report this figure0.1Income tax, Q2 FY2024, three months to 2024-06-30$50.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0001437749-25-025422.Report this figure0.1Income tax, Q3 FY2024, three months to 2024-09-30$60.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure0.1Income tax, Q4 FY2024, three months to 2024-12-31$89.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$49.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$49.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure0.1Income tax, Q3 FY2025, three months to 2025-09-30$78.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure0.1Income tax, Q4 FY2025, three months to 2025-12-31$94.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2026, three months to 2026-03-31$143.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure0.1Income tax, Q2 FY2026, three months to 2026-06-30$124.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure
Net income$m(4.6)Net income, Q3 FY2023, three months to 2023-09-30−$4.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-08, accession 0001437749-24-034193.Report this figure(9.6)Net income, Q4 FY2023, three months to 2023-12-31−$9.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-13, accession 0001437749-25-007521. Derived: 12-month figure less the 9-month figure.Report this figure(7.6)Net income, Q1 FY2024, three months to 2024-03-31−$7.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-08, accession 0001437749-25-015356.Report this figure(6.6)Net income, Q2 FY2024, three months to 2024-06-30−$6.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-07, accession 0001437749-25-025422.Report this figure(4.7)Net income, Q3 FY2024, three months to 2024-09-30−$4.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure(4.6)Net income, Q4 FY2024, three months to 2024-12-31−$4.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure(4.2)Net income, Q1 FY2025, three months to 2025-03-31−$4.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure(3.8)Net income, Q2 FY2025, three months to 2025-06-30−$3.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure(2.0)Net income, Q3 FY2025, three months to 2025-09-30−$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure(1.3)Net income, Q4 FY2025, three months to 2025-12-31−$1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure(2.1)Net income, Q1 FY2026, three months to 2026-03-31−$2.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure(3.2)Net income, Q2 FY2026, three months to 2026-06-30−$3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure
Diluted EPS$ per share(0.13)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2023-11-09, accession 0000719135-23-000056.Report this figurenot reported(0.22)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-05-09, accession 0000719135-24-000026.Report this figure(0.19)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-08-08, accession 0000719135-24-000038.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Basic EPS$ per share(0.13)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-08, accession 0001437749-24-034193.Report this figurenot reported(0.22)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0001437749-25-015356.Report this figure(0.19)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001437749-25-025422.Report this figure(0.14)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figurenot reported(0.10)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure(0.09)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure(0.05)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figurenot reported(0.05)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure(0.07)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure

Balance sheet

Cash and equivalents$27.6m, Q2 FY2026
Long-term debt$35.3m, Q2 FY2026
Shareholders' equity$10.7m, Q2 FY2026
Apyx Medical Corp, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m22.1Cash and equivalents, Q3 FY2023, at 2023-09-30$22.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0000719135-23-000056.Report this figure43.7Cash and equivalents, FY2023, at 2023-12-31$43.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-13, accession 0001437749-25-007521.Report this figure37.3Cash and equivalents, Q1 FY2024, at 2024-03-31$37.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0000719135-24-000026.Report this figure32.7Cash and equivalents, Q2 FY2024, at 2024-06-30$32.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0000719135-24-000038.Report this figure28.0Cash and equivalents, Q3 FY2024, at 2024-09-30$28.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-08, accession 0001437749-24-034193.Report this figure31.7Cash and equivalents, FY2024, at 2024-12-31$31.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-10, accession 0001437749-26-007471.Report this figure31.0Cash and equivalents, Q1 FY2025, at 2025-03-31$31.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0001437749-25-015356.Report this figure29.3Cash and equivalents, Q2 FY2025, at 2025-06-30$29.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001437749-25-025422.Report this figure25.1Cash and equivalents, Q3 FY2025, at 2025-09-30$25.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure31.7Cash and equivalents, FY2025, at 2025-12-31$31.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure31.1Cash and equivalents, Q1 FY2026, at 2026-03-31$31.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure27.6Cash and equivalents, Q2 FY2026, at 2026-06-30$27.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure
Current assets$m50.2Current assets, Q3 FY2023, at 2023-09-30$50.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000719135-23-000056.Report this figure70.4Current assets, FY2023, at 2023-12-31$70.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-13, accession 0001437749-25-007521.Report this figure61.9Current assets, Q1 FY2024, at 2024-03-31$61.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000719135-24-000026.Report this figure56.7Current assets, Q2 FY2024, at 2024-06-30$56.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000719135-24-000038.Report this figure52.2Current assets, Q3 FY2024, at 2024-09-30$52.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-08, accession 0001437749-24-034193.Report this figure56.4Current assets, FY2024, at 2024-12-31$56.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-10, accession 0001437749-26-007471.Report this figure51.9Current assets, Q1 FY2025, at 2025-03-31$51.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001437749-25-015356.Report this figure49.9Current assets, Q2 FY2025, at 2025-06-30$49.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001437749-25-025422.Report this figure48.8Current assets, Q3 FY2025, at 2025-09-30$48.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure58.5Current assets, FY2025, at 2025-12-31$58.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure54.8Current assets, Q1 FY2026, at 2026-03-31$54.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure53.2Current assets, Q2 FY2026, at 2026-06-30$53.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure
Total assets$m59.4Total assets, Q3 FY2023, at 2023-09-30$59.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000719135-23-000056.Report this figure79.2Total assets, FY2023, at 2023-12-31$79.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-13, accession 0001437749-25-007521.Report this figure70.7Total assets, Q1 FY2024, at 2024-03-31$70.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000719135-24-000026.Report this figure65.4Total assets, Q2 FY2024, at 2024-06-30$65.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000719135-24-000038.Report this figure60.7Total assets, Q3 FY2024, at 2024-09-30$60.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-08, accession 0001437749-24-034193.Report this figure64.8Total assets, FY2024, at 2024-12-31$64.8m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-10, accession 0001437749-26-007471.Report this figure60.2Total assets, Q1 FY2025, at 2025-03-31$60.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001437749-25-015356.Report this figure58.2Total assets, Q2 FY2025, at 2025-06-30$58.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001437749-25-025422.Report this figure57.4Total assets, Q3 FY2025, at 2025-09-30$57.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure66.8Total assets, FY2025, at 2025-12-31$66.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure63.0Total assets, Q1 FY2026, at 2026-03-31$63.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure61.1Total assets, Q2 FY2026, at 2026-06-30$61.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure
Current liabilities$m10.3Current liabilities, Q3 FY2023, at 2023-09-30$10.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000719135-23-000056.Report this figure12.7Current liabilities, FY2023, at 2023-12-31$12.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-13, accession 0001437749-25-007521.Report this figure10.6Current liabilities, Q1 FY2024, at 2024-03-31$10.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000719135-24-000026.Report this figure10.6Current liabilities, Q2 FY2024, at 2024-06-30$10.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000719135-24-000038.Report this figure9.6Current liabilities, Q3 FY2024, at 2024-09-30$9.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-08, accession 0001437749-24-034193.Report this figure10.7Current liabilities, FY2024, at 2024-12-31$10.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-10, accession 0001437749-26-007471.Report this figure9.5Current liabilities, Q1 FY2025, at 2025-03-31$9.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0001437749-25-015356.Report this figure10.6Current liabilities, Q2 FY2025, at 2025-06-30$10.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001437749-25-025422.Report this figure11.0Current liabilities, Q3 FY2025, at 2025-09-30$11.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure11.7Current liabilities, FY2025, at 2025-12-31$11.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure9.4Current liabilities, Q1 FY2026, at 2026-03-31$9.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure9.4Current liabilities, Q2 FY2026, at 2026-06-30$9.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure
Total liabilities$m25.9Total liabilities, Q3 FY2023, at 2023-09-30$25.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000719135-23-000056.Report this figure52.3Total liabilities, FY2023, at 2023-12-31$52.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-13, accession 0001437749-25-007521.Report this figure50.3Total liabilities, Q1 FY2024, at 2024-03-31$50.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000719135-24-000026.Report this figure50.5Total liabilities, Q2 FY2024, at 2024-06-30$50.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000719135-24-000038.Report this figure49.5Total liabilities, Q3 FY2024, at 2024-09-30$49.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-08, accession 0001437749-24-034193.Report this figure50.5Total liabilities, FY2024, at 2024-12-31$50.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-10, accession 0001437749-26-007471.Report this figure49.5Total liabilities, Q1 FY2025, at 2025-03-31$49.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0001437749-25-015356.Report this figure50.7Total liabilities, Q2 FY2025, at 2025-06-30$50.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001437749-25-025422.Report this figure51.3Total liabilities, Q3 FY2025, at 2025-09-30$51.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure52.0Total liabilities, FY2025, at 2025-12-31$52.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure49.9Total liabilities, Q1 FY2026, at 2026-03-31$49.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure50.0Total liabilities, Q2 FY2026, at 2026-06-30$50.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure
Long-term debt$m9.0Long-term debt, Q3 FY2023, at 2023-09-30$9.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-09, accession 0000719135-23-000056.Report this figure33.2Long-term debt, FY2023, at 2023-12-31$33.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-13, accession 0001437749-25-007521.Report this figure33.4Long-term debt, Q1 FY2024, at 2024-03-31$33.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-09, accession 0000719135-24-000026.Report this figure33.6Long-term debt, Q2 FY2024, at 2024-06-30$33.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-08, accession 0000719135-24-000038.Report this figure33.9Long-term debt, Q3 FY2024, at 2024-09-30$33.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-08, accession 0001437749-24-034193.Report this figure33.9Long-term debt, FY2024, at 2024-12-31$33.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-10, accession 0001437749-26-007471.Report this figure34.1Long-term debt, Q1 FY2025, at 2025-03-31$34.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-08, accession 0001437749-25-015356.Report this figure34.4Long-term debt, Q2 FY2025, at 2025-06-30$34.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-07, accession 0001437749-25-025422.Report this figure34.6Long-term debt, Q3 FY2025, at 2025-09-30$34.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure34.8Long-term debt, FY2025, at 2025-12-31$34.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure35.1Long-term debt, Q1 FY2026, at 2026-03-31$35.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure35.3Long-term debt, Q2 FY2026, at 2026-06-30$35.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m33.3Shareholders' equity, Q3 FY2023, at 2023-09-30$33.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-09, accession 0000719135-23-000056.Report this figure26.7Shareholders' equity, FY2023, at 2023-12-31$26.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-13, accession 0001437749-25-007521.Report this figure20.3Shareholders' equity, Q1 FY2024, at 2024-03-31$20.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-09, accession 0000719135-24-000026.Report this figure14.7Shareholders' equity, Q2 FY2024, at 2024-06-30$14.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-08, accession 0000719135-24-000038.Report this figure11.0Shareholders' equity, Q3 FY2024, at 2024-09-30$11.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-08, accession 0001437749-24-034193.Report this figure14.2Shareholders' equity, FY2024, at 2024-12-31$14.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-10, accession 0001437749-26-007471.Report this figure10.5Shareholders' equity, Q1 FY2025, at 2025-03-31$10.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-08, accession 0001437749-25-015356.Report this figure7.3Shareholders' equity, Q2 FY2025, at 2025-06-30$7.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-07, accession 0001437749-25-025422.Report this figure5.8Shareholders' equity, Q3 FY2025, at 2025-09-30$5.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001437749-25-033499.Report this figure14.5Shareholders' equity, FY2025, at 2025-12-31$14.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure12.8Shareholders' equity, Q1 FY2026, at 2026-03-31$12.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure10.7Shareholders' equity, Q2 FY2026, at 2026-06-30$10.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure

Cash flow

Operating cash flow−$3.5m, Q2 FY2026
Capital expenditure$66.0k, Q2 FY2026
Apyx Medical Corp, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k3,696Operating cash flow, Q3 FY2023, three months to 2023-09-30$3.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-08, accession 0001437749-24-034193. Derived: 9-month figure less the 6-month figure.Report this figure(2,212)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-13, accession 0001437749-25-007521. Derived: 12-month figure less the 9-month figure.Report this figure(6,341)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$6.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0001437749-25-015356.Report this figure(4,329)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$4.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001437749-25-025422. Derived: 6-month figure less the 3-month figure.Report this figure(4,440)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$4.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001437749-25-033499. Derived: 9-month figure less the 6-month figure.Report this figure(2,937)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$2.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure(702)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$702.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure(1,233)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001437749-26-026346. Derived: 6-month figure less the 3-month figure.Report this figure(3,536)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$3.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001437749-25-033499. Derived: 9-month figure less the 6-month figure.Report this figure(2,530)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure(572)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$572.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure(3,490)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$3.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001437749-26-026346. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k174Capital expenditure, Q3 FY2023, three months to 2023-09-30$174.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-08, accession 0001437749-24-034193. Derived: 9-month figure less the 6-month figure.Report this figure93.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$93.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-13, accession 0001437749-25-007521. Derived: 12-month figure less the 9-month figure.Report this figure35.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$35.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0001437749-25-015356.Report this figure289Capital expenditure, Q2 FY2024, three months to 2024-06-30$289.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001437749-25-025422. Derived: 6-month figure less the 3-month figure.Report this figure153Capital expenditure, Q3 FY2024, three months to 2024-09-30$153.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001437749-25-033499. Derived: 9-month figure less the 6-month figure.Report this figure245Capital expenditure, Q4 FY2024, three months to 2024-12-31$245.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure55.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$55.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure265Capital expenditure, Q2 FY2025, three months to 2025-06-30$265.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001437749-26-026346. Derived: 6-month figure less the 3-month figure.Report this figure519Capital expenditure, Q3 FY2025, three months to 2025-09-30$519.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001437749-25-033499. Derived: 9-month figure less the 6-month figure.Report this figure275Capital expenditure, Q4 FY2025, three months to 2025-12-31$275.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-10, accession 0001437749-26-007471. Derived: 12-month figure less the 9-month figure.Report this figure60.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$60.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001437749-26-015652.Report this figure66.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$66.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001437749-26-026346. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)34.64m, Q2 FY2024
Apyx Medical Corp, shares, quarterly
Line itemUnitQ3 FY20202020-09-30Q1 FY20212021-03-31Q2 FY20212021-06-30Q3 FY20212021-09-30Q1 FY20222022-03-31Q2 FY20222022-06-30Q3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30
Diluted shares (weighted)m shares34.2Diluted shares (weighted), Q3 FY2020, three months to 2020-09-3034,216,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2021-11-12, accession 0000719135-21-000072.Report this figure34.3Diluted shares (weighted), Q1 FY2021, three months to 2021-03-3134,302,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-05-12, accession 0000719135-22-000033.Report this figure34.3Diluted shares (weighted), Q2 FY2021, three months to 2021-06-3034,321,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-08-11, accession 0000719135-22-000063.Report this figure34.3Diluted shares (weighted), Q3 FY2021, three months to 2021-09-3034,330,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-11-10, accession 0000719135-22-000091.Report this figure34.4Diluted shares (weighted), Q1 FY2022, three months to 2022-03-3134,429,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-05-11, accession 0000719135-23-000027.Report this figure34.5Diluted shares (weighted), Q2 FY2022, three months to 2022-06-3034,464,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-08-11, accession 0000719135-23-000047.Report this figure34.6Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3034,569,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000719135-23-000056.Report this figure34.6Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3134,598,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0000719135-24-000026.Report this figure34.6Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3034,603,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000719135-24-000038.Report this figure34.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3034,642,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000719135-23-000056.Report this figure34.6Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3134,644,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0000719135-24-000026.Report this figure34.6Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3034,644,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000719135-24-000038.Report this figure

Shares outstanding: 42.12mShares outstanding, period not labelled, at 2026-08-0542,124,023 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001437749-26-026346.Report this figure at Aug 5, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. Listed shows no prices and gives no investment advice.